Literature DB >> 2578320

Cell surface expression of an in vitro recombinant class II/class I major histocompatibility complex gene product.

J McCluskey, R N Germain, D H Margulies.   

Abstract

Chimeric histocompatibility genes encoding the amino-terminal (beta 1) domain of the class II Ak beta polypeptide and the carboxy-terminal (C2, transmembrane, and intracytoplasmic) domains of either the class I H-2Ld or H-2Dd molecules were stably introduced into mouse L cells. Although both were transcribed, only 5' Ak beta/3' H-2Dd transformants had significant cell membrane expression of a 30-40 kd, heterogeneous glycoprotein containing Ak beta 1 and H-2Dd (C2) serological epitopes. These transformants had a unique pattern of reactivity with monoclonal antibodies previously identified as requiring the Ak beta 1 domain for recognition of complete I-A molecules. These results allow new insight into the structural requirements for cell surface expression of proteins and provide unique cellular reagents for the dissection of humoral and cell-mediated recognition of MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578320     DOI: 10.1016/0092-8674(85)90139-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  4 in total

Review 1.  Exon shuffling: new genes from old.

Authors:  D H Margulies; J McCluskey
Journal:  Surv Immunol Res       Date:  1985

2.  Genetic engineering of an H-2Dd/Q10b chimeric histocompatibility antigen: purification of soluble protein from transformant cell supernatants.

Authors:  D H Margulies; A L Ramsey; L F Boyd; J McCluskey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

3.  Alternative processing of H-2Dd pre-mRNAs results in membrane expression of differentially phosphorylated protein products.

Authors:  J McCluskey; L F Boyd; W L Maloy; J E Coligan; D H Margulies
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

4.  Fine mapping of epitopes by intradomain Kd/Dd recombinants.

Authors:  J P Abastado; C Jaulin; M P Schutze; P Langlade-Demoyen; F Plata; K Ozato; P Kourilsky
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.